The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

A new clinical trial suggests that semaglutide — the active ingredient in the widely used drugs Ozempic and Wegovy — may help ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Ozempic is not an inherently bad drug — it has genuine medical uses and life-changing potential for those who need it. But ...

GLP-1 drugs have revolutionised the treatment of obesity, but the very reason they are effective is also why it's vital to ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A new obesity 'wonder drug’ arrives on the Irish market today. The weight loss medication Wegovy, which is similar to Ozempic ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

A new study has revealed that the ingredients of the popular weight loss drug Ozempic are linked to hair loss.According to ...

Currently, Ozempic is only approved to treat type 2 diabetes. But in recent years, the semaglutide injection has become a ...